Page last updated: 2024-08-23

daunorubicin and digitonin

daunorubicin has been researched along with digitonin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broxterman, HJ; Dekker, H; Feller, N; Kuiper, CM; Lankelma, J; Versantvoort, CH1
Levy, SB; Martell, RL; Slapak, CA; Terashima, M1
Lankelma, J; Westerhoff, HV; Wielinga, PR1

Other Studies

3 other study(ies) available for daunorubicin and digitonin

ArticleYear
Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
    International journal of cancer, 1992, Apr-01, Volume: 50, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cell Membrane Permeability; Daunorubicin; Digitonin; DNA, Neoplasm; Drug Resistance; Humans; Hydrogen-Ion Concentration; Kinetics; L-Lactate Dehydrogenase; Membrane Glycoproteins; Tumor Cells, Cultured

1992
Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
    Biochemical pharmacology, 1996, Nov-22, Volume: 52, Issue:10

    Topics: 2,4-Dinitrophenol; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport, Active; Cell Line; Cell Membrane; Daunorubicin; Digitonin; Humans; Hydrogen-Ion Concentration; Kinetics; Mice; Sodium Azide; Subcellular Fractions; Uncoupling Agents; Vincristine

1996
The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells.
    European journal of biochemistry, 2000, Volume: 267, Issue:3

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Biological Transport, Active; Cell Compartmentation; Cell Line; Cell Membrane Permeability; Daunorubicin; Digitonin; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Idarubicin; Kinetics; Verapamil

2000